We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
ESROB | Estrella Resources Limited | 0.002 | 0.001 | 100.00% | 12,229,999 | 3 |
APS | Allup Silica Ltd | 0.057 | 0.028 | 96.55% | 27,580,361 | 1,138 |
LPE | Locality Planning Energy Holdings Limited | 0.055 | 0.021 | 61.76% | 33,644,993 | 28 |
HYTO | HyTerra Ltd | 0.003 | 0.001 | 50.00% | 1,500,000 | 3 |
TNC | True North Copper Limited | 0.10 | 0.028 | 38.89% | 7,211,062 | 279 |
RMX | Red Mountain Mining Ltd | 0.002 | 0.0005 | 33.33% | 12,051,679 | 8 |
RIE | Riedel Resources Ltd | 0.004 | 0.001 | 33.33% | 3,981,044 | 14 |
LSR | Lodestar Minerals Limited | 0.002 | 0.0005 | 33.33% | 2,077,222 | 3 |
MXO | Motio Limited | 0.029 | 0.007 | 31.82% | 257,349 | 6 |
MCL | Mighty Craft Limited | 0.025 | 0.006 | 31.58% | 1,325,790 | 26 |
VALDB | Valor Resources Limited | 0.065 | 0.015 | 30.00% | 689,564 | 17 |
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2023.
PORTLAND, Ore., March 27, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (NASDAQ: EAST) ("Eastside" or the "Company"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality artisan products around premium spirits, digital can printing, co-packing and mobile filling, will report its financial year end results after the market close on Monday, April 1, 2024. The Company will host a conference call on Tuesday April 2, 2024 at 8:30am Eastern Time to review results.
Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, IoT systems, and connectivity service provider, today announced the integration of Non-Terrestrial Network (NTN) support into its HL series LPWA modules, specifically the HL7810 and HL7812. This significant advancement showcases a major leap forward in enabling uninterrupted global connectivity even amidst the most challenging conditions.
Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,700.09 | 1,235.52 | 1.78% | 1.39T | 5,650,000,447 |
ETH | Ethereum | 3,561.94 | 61.88 | 1.77% | 428.31B | 2,893,146,735 |
USDT | Tether USD | 1.00 | 0.00056 | 0.06% | 97.84B | 380,559,482 |
BNB | Binance Coin | 581.01 | 6.89 | 1.20% | 91.9B | 397,431,985 |
SOL | Solana | 187.89 | 1.77 | 0.95% | 82.94B | 1,292,223,372 |
STETH | stETH | 3,546.59 | 82.16 | 2.37% | 34.8B | 5,157,366 |
XRP | Ripple | 0.6285 | 0.017 | 2.78% | 34.26B | 545,902,559 |
DOGE | Dogecoin | 0.22325 | 0.03321 | 17.48% | 32.04B | 2,873,410,422 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,283,382,888 |
ADA | Cardano | 0.6497 | 0.0021 | 0.32% | 22.87B | 140,852,702 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions